Effects of Visual Biofeedback Therapy in Parkinson's Patients
Trial
N/A
Unknown
April 12, 2022
Validity Reliability of The Dubousset Functional Test in Parkinson Disease
Trial
N/A
Completed
April 11, 2022
Molecular Analysis of Human Neural Stem Cells
Trial
N/A
Withdrawn
April 11, 2022
Transplantation of Neural Stem Cell-Derived Neurons for Parkinson's Disease
Trial
Phase 1
Withdrawn
April 11, 2022
Intelligibility Assessment for Parkinson's Disease
Trial
N/A
Completed
April 11, 2022
Simultaneous DBS of the GPi and the NBM in Patients With Parkinson's Disease and Mild Cognitive Impairment
Trial
N/A
Unknown
April 10, 2022
The Effect of Gluten-free Diet on Parkinsonism
Trial
N/A
Unknown
April 7, 2022
Deep Brain Stimulation on Dual-task Gait Performance in PD
Trial
N/A
Unknown
April 5, 2022
Interactive POWER Rehabilitation System on Rehabilitation Training for Patients With Parkinson's Disease
Trial
N/A
Unknown
April 3, 2022
Effects of Nordic Walking Exercise on Gait, Motor/Non-motor Symptoms, and Exercise Biomarkers in Parkinson's Disease
Trial
N/A
Completed
March 30, 2022
Evaluation of the Infinity Deep Brain Stimulation Electrode Screening Mode Tool
Trial
N/A
Completed
March 30, 2022
Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia
Trial
Phase 2
Completed
March 30, 2022
Development of a Face Valid Executive Functioning Task
Trial
N/A
Completed
March 30, 2022
Efficacy of Transcranial Direct Current Stimulation In Parkinson's Disease MCI
Trial
N/A
Completed
March 30, 2022
Biomarkers in Parkinsonian Syndromes
Trial
N/A
Unknown
March 30, 2022
A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease
Trial
Phase 2
Unknown
March 28, 2022
Modifiable Variables in Parkinsonism (MVP)
Trial
N/A
Recruiting
March 24, 2022
Bracing for Walking in Parkinson's Disease
Trial
N/A
Completed
March 22, 2022
Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment
Trial
Phase 1
Completed
March 21, 2022
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Trial
Phase 1
Completed
March 20, 2022